CHROMagar: Single-step, Chromogenic Testing Media for Colorful Microbial Detection
The Widest Range of Chromogenic Media Available on the Market
CHROMagar ™ supplies the widest range of chromogenic culture media available today
CHROMagar ™ covers applications in clinical bacteriology, industrial microbiology, quality control for food and beverage industries, water testing and environmental monitoring, among others. These media allow for a quicker and simpler detection of key clinical and food-borne pathogens, including Salmonella, Staph aureus, Candida albicans, E.coli O157, Group B Strep, E.coli, Listeria, Vibrio and Pseudomonas.
Research-driven and high-tech, CHROMagar ™ consists of a select team of highly-trained scientists and technicians led by its founder Dr. Rambach. A leader in the innovative field of chromogenic culture media technology, CHROMagar ™ is a commercially successful and growing enterprise with efficient international reach through its worldwide distribution network.
CHROMagar ™ offers an innovative product line of selective microbiological testing media permitting,in a single step, the isolation and differentiation of pathogenic micro-organisms by colony colors. All Chromagar products distributed and sold by DRG are CE marked.
From pioneer research to cutting edge techniques, CHROMagar ™ leads the way in chromogenic media.
CHROMagar™ Microbiology was incorporated in 1993 by inventor, and pioneer in chromogenic media technology, Alain Rambach. Established in the heart of Paris (France), not far from the famous Pasteur Institute where Dr. Rambach began his research career, CHROMagar™ provides innovative chromogenic culture media solutions, designed to improve and simplify traditional culture techniques. CHROMagar™ is at the cutting edge of a diagnostic field that developed out of Dr. Rambach’s pioneering research in the late 1970’s.
The Strength of CHROMagar™
30 years’ experience, specialization and know-how.
A pioneer and specialist in chromogenic culture media technology, CHROMagar™, has been exploring both clinical and industrial microbial applications for over 30 years.
Innovation and research
At the heart of its activity CHROMagar™ is fully committed to research with more than 50% of its human resources involved in research. CHROMagar™’s mission is to find detection solutions for today’s infection control challenges such as those posed by multi-resistance bacteria.
Worldwide recognition and an international distribution network
Dr. Rambach is well known in the microbiology community for his inventions. Meanwhile, renowned international scientists have studied the performance of CHROMagar™ media. These studies have heightened awareness of CHROMagar™’s technology and are available online.
CHROMagar® Brochures and Instruction Manuals
News and Updates
DRG is proud to announce that our TM-CA 72-4 ELISA Kit (EIA-5071) has been used in a recent cancer study done by NYU Winthrop Hospital. The DRG TM-CA 72-4 ELISA Kit is for sale in the United States as an RUO product and is CE marked for global sales. Please see...read more
DRG International, Inc., the authorized distributor for CHROMagar, recently attended the 2017 ASM Microbe General Meeting of the American Society for Microbiology in New Orleans, LA from June 1, 2017 – June 4, 2017. Attendees (pictured above, l to r) were Mr. Alberto...read more
Dear Customers, Suppliers, and Friends, We regret to inform you that Dr. Cyril E. Geacintov passed away on Tuesday, May 23. His death was sudden and unexpected. In his usual driven style he was working in the office until a few days ago and challenging his team on how...read more
DRG International, inc. recently launched our brand new Ecommerce site for USA customers! Click here to shop over 180 ELISA, Salivary ELISA, and CHROMagar products now: https://store.drg-international.com/ The Ecommerce store has over 180 products that are FDA...read more
DRG Booth with Visitors. From Left: Mr. Gideon Lim; Dr. Cyril E. Geacintov, CEO & Founder of DRG; Dr.Aw Tar Choon, MD at Changi General Hospital in Singapore; Mrs. Josephine Teo; Mrs. Elke Geacintov; Mr. Wilhelm Sanger. We are pleased to announce that the DRG...read more
DRG’s CA 72-4 ELISA Kit (EIA-5071), which uses antibodies licensed from the NIH, has been used in a recent study conducted by Winthrop University. The study used the DRG CA 72-4 ELISA Kit (EIA-5071) to explore the expression of CA72-4 compared to current FDA-approved...read more
DRG is pleased to officially announce that we are going to Medlab Dubai from February 6th-February 9th, 2017 at the Dubai International Convention & Exhibition Centre, attended by over 10,000 delegates. The conference features 11 CME-accredited conference...read more
We sat down with the top executives and staff of DRG at the 2016 AACC Annual Meeting and asked them questions about what makes them the worldwide leader in diagnostics. These are the key takeaways the top executives at DRG want you to remember. Michael Martini (full...read more
DRG’s staff is diverse and the company maintains a global presence requiring its staff to speak multiple languages as well as travel the world visiting DRG’s many offices and events. We sat down with the top executives and staff of DRG at the 2016 AACC Annual Meeting...read more
We sat down with the top executives and staff of DRG at the 2016 AACC Annual Meeting and asked them each about what DRG’s strengths are and how they add value to customers and business partners. Wilhelm Saenger (full profile) Our flexibility, flexibility and...read more
As a worldwide leader in diagnostics with several locations spanning the globe, DRG is proud to have a diverse, multilingual staff. We sat down with the top executives and staff of DRG at the 2016 AACC Annual Meeting and asked each of them about the languages they...read more
Maximilian Saenger, son of the General Manager of DRG Germany (Wilhelm Saenger), traveled to Bishkek, capital of Kyrgyz Republic, during his summer vacation in August 2016.read more